Page results
-
This information has been written for patients who have been referred for pelvic radiotherapy for a gynaecological cancer.
-
Many of our consultants in infectious and tropical diseases hold the only dedicated NHS positions in their respective fields, including parasitology, leprosy, leishmaniasis, and tropical dermatology.
-
For patients aged 13-18 we have a dedicated team covering a range of conditions, particularly specialising in reconstructive urology.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
This is an easy read page for patients with deep vein thrombosis (DVT).
-
A safeguarding clinic dedicated to the long term needs of children and young people who have problems related to Sexual, gynaecological or genito-urinary health, Complex maltreatment including sexual abuse, female genital mutilation, factitious illness and related issues. We also see unaccompanied children, refugees and looked after children.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
Coping with nausea patient information page.
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
File results
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0326 - Risk management system reporting rates for adverse events
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy